Nilsson Abraham, Alkner Björn, Wetterlöv Patrick, Wetterstad Stefan, Palm Lars, Schilcher Jörg
Department of Orthopedics and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Department of Orthopedics, Regional Hospital Eksjö, Region Jönköping County and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
BMC Musculoskelet Disord. 2019 Jan 5;20(1):15. doi: 10.1186/s12891-018-2394-y.
The intense ischemic pain of acute compartment syndrome can be difficult to discriminate from the pain related to an associated fracture. Lacking objective measures, the decision to perform fasciotomy is often only based on clinical findings and performed at a low threshold. Biomarkers of muscle cell damage might help to identify and monitor patients at risk. In patients with fractures, however, markers of muscle cell damage could be elevated because of other reasons associated with the trauma, which would make interpretation difficult. In a review of all patients who underwent emergency fasciotomy in our health care district we aimed to investigate the decision-making process and specifically the use of biomarkers in patients with and without fractures.
In the southeast health care region of Sweden 79 patients (60 men) with fractures (median age 26 years) and 42 patients (34 men) without associated fractures (median age 44 years) were treated with emergency fasciotomy of the lower leg between 2007 and 2016. Differences in clinical findings, p-myoglobin and p-creatine phosphokinase as well as pressure measurements were investigated.
P-myoglobin was analyzed preoperatively in 20% of all cases and p-creatine phosphokinase in 8%. Preoperative levels of p-myoglobin were lower in patients with fractures (median 1065 μg/L, range 200-3700 μg/L) compared with those without fractures (median 7450 μg/L, range 29-31,000 μg/L), p < 0.05. Preoperative intracompartmental pressure was lower in the fracture group (median 45 mmHg, range 25-90 mmHg) compared with those without fractures (median 83 mmHg, range 18-130 mmHg), p < 0.05.
Biomarkers are seldom used in the context of acute fasciotomy of the lower leg. Contrary to our expectations, preoperative levels of p-myoglobin and intracompartmental pressures were lower in fracture patients. These findings support differences in the underlying pathomechanism between the groups and indicate that biomarkers of muscle cell necrosis might play a more important role in the diagnosis of acute compartment syndrome than previously thought.
急性骨筋膜室综合征剧烈的缺血性疼痛可能难以与相关骨折引起的疼痛相区分。由于缺乏客观指标,行筋膜切开术的决策往往仅基于临床发现,且阈值较低。肌肉细胞损伤的生物标志物可能有助于识别和监测有风险的患者。然而,在骨折患者中,肌肉细胞损伤标志物可能因与创伤相关的其他原因而升高,这会使解读变得困难。在对我们医疗保健区所有接受急诊筋膜切开术的患者进行的回顾中,我们旨在调查决策过程,特别是骨折患者和非骨折患者生物标志物的使用情况。
在瑞典东南部医疗保健地区,2007年至2016年间,79例骨折患者(60例男性)(中位年龄26岁)和42例无相关骨折患者(34例男性)(中位年龄44岁)接受了小腿急诊筋膜切开术。研究了临床发现、肌红蛋白原(p-肌红蛋白)和肌酸磷酸激酶原(p-肌酸磷酸激酶)以及压力测量值的差异。
所有病例中20%进行了术前p-肌红蛋白分析,8%进行了术前p-肌酸磷酸激酶分析。骨折患者术前p-肌红蛋白水平(中位值1065μg/L,范围200 - 3700μg/L)低于无骨折患者(中位值7450μg/L,范围29 - 31000μg/L),p < 0.05。骨折组术前骨筋膜室内压力(中位值45mmHg,范围25 - 90mmHg)低于无骨折组(中位值83mmHg,范围18 - 130mmHg),p < 0.05。
生物标志物在小腿急性筋膜切开术中很少使用。与我们的预期相反,骨折患者术前p-肌红蛋白水平和骨筋膜室内压力较低。这些发现支持了两组潜在病理机制的差异,并表明肌肉细胞坏死的生物标志物在急性骨筋膜室综合征的诊断中可能比以前认为的发挥更重要的作用。